Weight gain in diabetes results from a tangle of biological forces, not a single cause. Insulin, whether produced by your own body or injected, is a powerful storage hormone that locks fat inside cells, retains sodium and water, and shifts your metabolism in ways that favor calorie retention. On top of that, several common diabetes medications amplify the effect, your brain’s appetite circuits can become resistant to insulin’s satiety signals, and treating high blood sugar itself eliminates a calorie-leak pathway that was keeping weight artificially low. The picture is more layered than most people realize, and understanding each piece helps explain why the scale moves even when eating habits haven’t changed much.
The Calorie Leak That Disappears With Treatment
When blood sugar is poorly controlled, your kidneys dump glucose into urine. That glucose carries calories with it. In animal models of uncontrolled diabetes, urinary glucose loss exceeded 12 grams per day, representing more than 30 percent of total energy intake, and correcting blood sugar with insulin therapy dramatically reduced that loss while producing rapid weight gain.1PubMed. Energy loss via urine and faeces–a combustive analysis in diabetic rats and the impact of antidiabetic treatment on body weight The same pattern shows up in humans. In one study, people with type 2 diabetes who started sulfonylurea therapy saw their daily urinary glucose loss plummet from roughly 128 grams to about 11 grams. To keep their weight stable during the study, researchers had to cut their daily calorie intake by nearly 300 calories, because those leaked calories were no longer leaving their bodies.2Diabetes. Increased Resting Metabolic Rates in Obese Subjects with Non-insulin-dependent Diabetes Mellitus and the Effect of Sulfonylurea Therapy
This is a frustrating reality: getting your blood sugar under better control is unambiguously good for your long-term health, but it also plugs a calorie drain you may not have known existed. On top of that, resting metabolic rate itself drops when blood sugar improves. The same study found that treating hyperglycemia with a sulfonylurea lowered resting energy expenditure measurably. A separate analysis concluded that improved blood sugar control promotes weight gain by decreasing both basal metabolic rate and glucosuria together.3PubMed. Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus So you are retaining more calories and burning fewer of them at rest, a double hit.
Insulin Is a Storage Hormone
Insulin does far more than shuttle glucose into cells. One of its fundamental jobs is to inhibit the breakdown of stored fat. Research has shown that insulin suppresses fat breakdown in fat cells through a molecular pathway that reduces the production of a key fat-dissolving enzyme, promoting triglyceride storage instead.4PubMed Central. Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway Insulin also works through a separate mechanism involving an enzyme inside fat cells that degrades the chemical signals that would otherwise trigger fat release.5PubMed Central. Brain insulin controls adipose tissue lipolysis and lipogenesis
In practical terms, when insulin levels are high, your body is in storage mode. Fat gets packed away, and the signals to release it are suppressed. For someone with type 2 diabetes who already has high circulating insulin due to insulin resistance, or someone with type 1 diabetes taking external insulin, this storage effect is essentially running all the time. It becomes very difficult for the body to access stored fat for energy, even during calorie restriction, because insulin keeps the fat locked in place. This is one reason why people with diabetes can feel like weight loss is uniquely hard for them compared to non-diabetic friends who eat the same way.
Why Injected Insulin Hits Harder Than Natural Insulin
Your pancreas releases insulin directly into the portal vein, which flows straight to the liver. The liver acts as a first-pass filter, clearing a large portion of that insulin before it reaches the rest of your body. When you inject insulin under the skin, it skips the liver entirely and enters the general circulation, meaning your muscles, fat tissue, and other organs see artificially high insulin levels. A review in the journal Diabetes described this as a fundamental problem: injecting insulin into the peripheral circulation bypasses first-pass hepatic clearance, leading to whole-body insulin resistance as an unintended metabolic consequence.6Diabetes. The Peripheral Peril: Injected Insulin Induces Insulin Insensitivity in Type 1 Diabetes
This matters for weight because peripheral hyperinsulinemia amplifies every storage effect discussed above. Your fat cells see more insulin than they would under normal physiology, so they store more fat and release less. Your liver, paradoxically, gets less insulin than it should, so it doesn’t suppress glucose production as effectively, and you may need even higher total doses to hit your blood sugar targets. The cycle is self-reinforcing: more insulin leads to more resistance, which leads to higher doses, which leads to more fat storage. In people with type 1 diabetes, intensive insulin therapy was associated with a gain of roughly 2.4 kilograms of fat mass, confirming that the fat-storage signal of injected insulin is measurably potent.7PubMed. Intensive insulin therapy and weight gain in IDDM
Hypoglycemia and Defensive Eating
Low blood sugar is one of the most feared short-term complications of insulin and certain oral medications. The experience is unpleasant and sometimes dangerous, so people learn to prevent and treat it by eating, often quickly and more than strictly necessary. Over time, this creates a pattern of extra calorie intake that adds up. Beyond the immediate events, the anxiety surrounding potential lows can change eating behavior in subtler ways: snacking before bed “just in case,” keeping high-calorie rescue foods nearby and nibbling on them even when blood sugar is fine, or eating preemptively before exercise.
The consequences of hypoglycemia extend well beyond the acute episode. Repeated lows are linked to weight gain, reduced quality of life, and a cycle of overcorrection that can keep blood sugar swinging between highs and lows.8PubMed Central. Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes This behavioral component is biological in its origin: your brain registers low blood sugar as a survival threat and triggers powerful hunger signals that are very difficult to override through willpower alone.
How Insulin Resistance Rewires Appetite
Insulin doesn’t just work on your muscles and fat cells. It acts in the brain, where it helps regulate appetite and the reward you feel from eating. In people with insulin resistance, the brain becomes less responsive to insulin’s signals. One study found that in insulin-resistant subjects, insulin’s effect on brain glucose metabolism was significantly blunted compared to insulin-sensitive people, especially in brain regions that control appetite and reward. The change in the ventral striatum, a region strongly tied to food craving, was less than half as large in the resistant group.9PubMed. Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome?
When those brain circuits don’t respond properly to insulin, you don’t get the normal “I’ve had enough” signal after eating. Food, particularly calorie-dense food, stays more rewarding for longer. This helps explain why insulin resistance and overeating reinforce each other: the worse your insulin resistance gets, the less effectively your brain registers satiety, which drives more eating, which worsens insulin resistance.
Ghrelin, the hunger hormone, adds another wrinkle. Insulin normally helps suppress ghrelin after meals, which is part of what makes you stop feeling hungry. In people with severe insulin deficiency, that postmeal ghrelin suppression fails, and hunger persists even after eating. Research has shown that insulin is essential for meal-induced ghrelin suppression, and that the absence of this effect may explain the excessive appetite seen in poorly controlled type 1 diabetes.10Diabetes. Insulin is Required for Prandial Ghrelin Suppression in Humans So whether you have too little insulin (uncontrolled type 1) or your brain can’t hear insulin’s signal (type 2 with resistance), the appetite system is disrupted in ways that push toward overconsumption.
Fluid Retention and the Scale
Not all weight gain in diabetes is fat. Insulin has a sodium-retaining effect on the kidneys, which has long been suspected to contribute to the fluid retention and hypertension seen in insulin-resistant states.11PubMed Central. Sodium-retaining effect of insulin in diabetes When you start or intensify insulin therapy, your body may hold onto more water, causing a rapid bump on the scale that feels like fat gain but is partly fluid.
Certain diabetes medications make this worse. Thiazolidinediones (a class of insulin-sensitizing pills) are particularly notorious for causing fluid retention. Research has shown that these drugs increase plasma volume and the fluid content of abdominal fat pads, and that increased vascular permeability in fat tissue may contribute to the edema and body weight gain they cause.12PubMed Central. Renal and vascular mechanisms of thiazolidinedione-induced fluid retention In mouse models, the same drug class raised body weight and plasma volume while also decreasing hematocrit, a sign of blood dilution from excess fluid.13PubMed Central. Thiazolidinedione-induced fluid retention is independent of collecting duct alphaENaC activity The practical implication is that if you’ve recently started one of these medications and see the scale jump quickly, a meaningful portion of that is likely water rather than fat.
The Cortisol Connection
Diabetes and obesity both change the way your body handles stress hormones. In obese individuals, concentrations of cortisol are elevated in fat tissue due to increased local activity of an enzyme that converts inactive cortisone into active cortisol.14PubMed Central. The Hypothalamic-Pituitary-Adrenal Axis, Obesity, and Chronic Stress Exposure: Sleep and the HPA Axis in Obesity Cortisol promotes the accumulation of visceral fat, the deep belly fat that is metabolically active and drives insulin resistance. Research has linked dysfunction of the body’s stress-response axis to visceral fat accumulation, elevated free fatty acids, and the development of insulin resistance itself.15PubMed. Visceral obesity and diabetes
In people with type 2 diabetes specifically, cortisol activity after a suppression test was independently associated with waist circumference, even after accounting for sex, fasting insulin, and other factors.16PubMed. Hyperactivity of the hypothalamic-pituitary-adrenal axis in patients with type 2 diabetes and relations with insulin resistance and chronic complications This creates another vicious cycle: visceral fat produces more local cortisol, cortisol promotes more visceral fat, and both worsen insulin resistance, making blood sugar harder to control and weight harder to lose.
Sleep Disruption and Circadian Misalignment
People with diabetes are disproportionately affected by sleep problems, including obstructive sleep apnea, insomnia, and disrupted circadian rhythms from shift work or night eating. These are not just quality-of-life issues; they directly alter metabolism. Sleep deficiencies and circadian disruption contribute to metabolic dysregulation that can promote weight gain, potentially by changing the timing and amount of food intake, disrupting energy balance, impairing glucose tolerance, and worsening insulin sensitivity.17PubMed Central. Metabolic consequences of sleep and circadian disorders
Poor sleep also raises cortisol and lowers leptin, your body’s long-term satiety signal, while boosting ghrelin. For someone with diabetes who is already fighting blunted appetite regulation and elevated cortisol, chronic sleep deprivation stacks another biological force on top. This is part of why clinicians increasingly consider sleep quality an essential piece of diabetes management, not just an afterthought.
Gut Bacteria and Energy Harvesting
The gut microbiome has emerged as another player in the obesity-diabetes nexus. In animal models, an altered gut bacterial composition has been connected to obesity, insulin resistance, and diabetes through several mechanisms, including increased energy extraction from food, changes in fatty acid metabolism in fat tissue and the liver, and modulation of gut hormones that influence appetite.18PubMed Central. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? The idea is that certain bacterial populations are better at squeezing calories from the same food. If your microbiome shifts toward these species, as it tends to in insulin-resistant and obese individuals, you may absorb more energy from the same meal than someone with a different gut bacterial profile. Research in this area is still young, and no one has yet shown that correcting the microbiome alone reverses diabetic weight gain, but it’s a real physiological variable and likely contributes to individual differences in how easily people gain weight.
Lipohypertrophy at Injection Sites
For people who inject insulin, a specific localized form of weight gain can develop: lipohypertrophy. These are fatty lumps that form under the skin at sites where insulin is injected repeatedly. They are the most common injection-site side effect of insulin therapy and consist of local fat tissue overgrowth that can progress to sizable masses causing discomfort.19PubMed. Prevention of insulin-induced lipohypertrophy by coadministration of a low dose of high-affinity PI3K inhibitors Lipohypertrophy is more than a cosmetic issue. Injecting into a lumpy site changes how insulin is absorbed, often making it less predictable, which can lead to both highs and lows and the need for higher doses, feeding back into the systemic weight gain cycle.20PubMed. Lipohypertrophy and Insulin: An Old Dog That Needs New Tricks Rotating injection sites consistently is the main prevention strategy, though many people fall into habits of reusing the same spots.
Amylin and the Missing Co-Hormone
Insulin isn’t the only hormone secreted by the beta cells of the pancreas. Amylin is co-released alongside insulin and plays a role in controlling both meal size and longer-term body weight. It works by stimulating neurons in the hindbrain that tell you to stop eating and appears to function as an adiposity signal, reflecting the body’s fat stores alongside circulating glucose.21PubMed Central. Pancreatic signals controlling food intake; insulin, glucagon and amylin In type 1 diabetes, where the beta cells are destroyed, amylin production is lost entirely. In advanced type 2, it is severely blunted. When you inject insulin to replace what the pancreas can’t make, you replace only one half of the beta-cell hormonal output. The missing amylin means you lose a natural brake on appetite, which may partially explain why insulin therapy tends to increase food intake.
Newer Medications That Push Back Against Weight Gain
The biological story is not all bad news. Two newer classes of diabetes drugs work specifically against several of the weight-gain mechanisms described above. SGLT2 inhibitors take advantage of the very calorie-leak mechanism that disappearing glucosuria removes. They work by blocking glucose reabsorption in the kidneys, deliberately forcing glucose out through urine and producing weight loss through increased caloric excretion, independent of insulin.22PubMed Central. SGLT2 Inhibitors: Multifaceted Therapeutic Agents in Cardiometabolic and Renal Diseases In effect, they recreate the calorie leak in a controlled, beneficial way while also lowering blood sugar.
GLP-1 receptor agonists tackle the appetite side of the equation. They promote weight loss by suppressing appetite, enhancing satiety, and slowing gastric emptying, working through both central brain pathways and peripheral metabolic processes.23The American Journal of Medicine. Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation For someone whose brain reward circuits have become insulin-resistant and whose ghrelin regulation is impaired, a GLP-1 agonist can restore some of the satiety signaling that diabetes had disrupted. The combination of an SGLT2 inhibitor and a GLP-1 agonist is increasingly used precisely because they target different weight-gain mechanisms simultaneously.
The Thrifty Genotype Backdrop
Behind all of these individual mechanisms sits an evolutionary framework that may explain why the human body is so stubbornly efficient at gaining and holding weight. The thrifty hypothesis proposes that certain genes involved in efficient fat storage and deposition were positively selected for because they helped our ancestors survive periods of famine.24PubMed Central. Impact of Early Life or Intrauterine Factors and Socio-Economic Interaction on Diabetes – An Evidence on Thrifty Hypothesis In an environment of constant food availability, those same genes become a liability, pushing the body toward fat accumulation and insulin resistance. People with type 2 diabetes may carry a genetic load that is especially well-tuned for calorie conservation, which means the biological forces driving weight gain are amplified in exactly the population least able to afford it metabolically. This isn’t a proven explanation for any individual’s weight trajectory, but it helps explain why the metabolic deck feels stacked: the same biology that made your ancestors good survivors makes your body extremely reluctant to let go of stored energy.